The global health challenge posed by Human Immunodeficiency Virus (HIV) necessitates innovative strategies for combatting the virus and enhancing treatment outcomes. This research delves into the potential of gamma-delta (γδ) T cells in HIV control, with a specific focus on the less-explored facets of their functionality and untapped therapeutic capabilities. The paper comprehensively reviews current literature on γδ T cells, highlighting their distinctive features and their role in bridging innate and adaptive immune responses. Additionally, the study explores recent advancements in unraveling the elusive characteristics of these cells and their potential contribution to HIV control. The outcomes of this research propose promising avenues for leveraging γδ T cells in the ongoing efforts to combat HIV.
No takes yet. Share an insight, caveat, or question.
Aleksander Jensen (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: